Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008


CHARENTON-LE-PONT, France, August 28 /PRNewswire-FirstCall/ --

- A Solid First-Half Performance

- Net Profit Up 16.8% at Constant Exchange Rates

- Essilor Launches a Share Buyback Program

The Board of Directors of Essilor International, the world leader in ophthalmic optics, has approved the financial statements for the six months ended June 30, 2008.

EUR millions First-half 2008 First-half 2007 % change % change

at constant

exchange

rates

Revenue 1,520.2 1,476.9 +2.9% +9.6%

Contribution margin 18.2% 18.1% - -

Profit attributable 198.3 181.9 +9.0% +16.8%

to equity holders of

Essilor International

Basic earnings per 0.96 0.88(1) +8.1% +15.8%

share (in EUR)

(1) Adjusted for the two-for-one stock split on July 16, 2007

The highlights of the first half were:

- Growth (excluding the currency effect) of 9.6%

- Sustained business growth in North America, Latin America,

the ASEAN countries, China and India.

- Successful new products, notably the sixth-generation of

Transitions(R) variable-tint lenses and Crizal Avance(TM)

anti-reflective lenses with Scotchgard(TM) Protector.

- High profitability, with a contribution margin of 18.2% that

was slightly higher than the figure reported for full-year 2007.

- A 9% increase in profit attributable to equity holders of

Essilor International, for a net margin of 13%.

- An ongoing external growth strategy, with the acquisition of

13 companies representing approximately EUR70 million in full-year

revenue. '/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... BEIJING , July 24, 2015 Origin Agritech ... supplier of crop seeds in China , ... third quarter fiscal year 2015 ended June 30, 2015, before ... The Company will host a teleconference on August 5th, 2015, ... time to discuss the results. To participate in ...
(Date:7/24/2015)... 2015 , Adds integrated small ... product offering for chronic kidney disease and oncology patients ... complications and dermatology , Increases group revenue and ... ,the Company"), a leading China -based ... biopharmaceutical products, today announced that it has acquired the ...
(Date:7/23/2015)... LOS ANGELES , July 23, 2015 ImmunoCellular ... plans to report financial results for the second quarter 2015 ... hold a conference call and webcast on that day at ... results and provide a business update. The call will be ...   , , , LIVE CALL: ...
(Date:7/23/2015)... , ... July 23, 2015 , ... Science and technology ... to new drug therapies and devices – according to Susan Chang, MD, director of ... session on how science and new technology are impacting the development of new treatments ...
Breaking Biology Technology:Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 2Origin Agritech Limited to Announce Third Quarter Fiscal 2015 Unaudited Financial Results on August 5th, 2015 33SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3
... Milwaukee TeraMedica has developed a ... at the Mayo Clinic and UW-Madison, is designed to ... than individual departments. , ,Paul Markham, vice president of ... software when he saw that medical firms were designing ...
... a bill that allows researchers to work together without ... in a patent dispute. After a 1997 court decision, ... art, said Andy Cohn, spokesperson for the Wisconsin ... patent claim though it has caused little trouble ...
... After two days of demostrating Wisconsin's breakthroughs in biotechnology, ... last Wednesday with a discussion of what the state must ... praised the strides Wisconsin has made in research, but explained ... , ,Tom Still, moderator of the panel and president of ...
Cached Biology Technology:TeraMedica offers system integration tool for hospitals 2Out-of-state VCs offer advice on biotech investments 2Out-of-state VCs offer advice on biotech investments 3
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Boyce Thompson Institute Associate Scientist Thomas Brutnell is ... researchers who are attempting to solve one of the ... to predict how plants will grow and develop based ... where they are found or planted. Solving this problem ...
... BLOOMINGTON, Ind. -- Two recently diverged populations of a ... contribute to the reproductive isolation that accompanies the origin ... of organic compounds present in the preen oils of ... Ecology . "There,s so much we don,t know ...
... play a major role in how people respond to stress, ... journal Psychophysiology , the investigation was led by scientists ... in collaboration with colleagues from the Universit du Qubec ... who are more defensive are at increased cardiovascular risk, whereas ...
Cached Biology News:BTI's Brutnell leads part of NSF Computational Plant Biology Research System 2BTI's Brutnell leads part of NSF Computational Plant Biology Research System 3Could smell play a role in the origin of new bird species? 2Could smell play a role in the origin of new bird species? 3Men and women respond differently to stress 2